From the Food and Drug Administration

JAMA. 1998 Mar 4;279(9):645.
No abstract available

MeSH terms

  • Administration, Inhalation
  • Advertising / standards*
  • Anti-Bacterial Agents / administration & dosage*
  • Cystic Fibrosis / drug therapy
  • Drug Approval
  • Drug Industry / standards*
  • Drugs, Generic* / standards
  • Humans
  • Hypersensitivity / etiology*
  • Latex / adverse effects*
  • Telecommunications
  • Tobramycin / administration & dosage*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Bacterial Agents
  • Drugs, Generic
  • Latex
  • Tobramycin